Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib)

E. Schollen, L. Dorland, T. J. De Koning, O. P. Van Diggelen, J. G M Huijmans, T. Marquardt, Dusica Babovic-Vuksanovic, M. Patterson, F. Imtiaz, B. Winchester, M. Adamowicz, E. Pronicka, H. Freeze, G. Matthijs

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

CDG-Ib is the 'gastro-intestinal' type of the congenital disorders of glycosylation (CDG) and a potentially treatable disorder. It has been described in patients presenting with congenital hepatic fibrosis and protein losing enteropathy. The symptoms result from hypoglycosylation of serum and other glycoproteins. CDG-Ib is caused by a deficiency of mannose-6-phosphate isomerase (synonym: phosphomannose isomerase, EC 5.3.1.8), due to mutations in the MPI gene. We determined the genomic structure of the MPI gene in order to simplify mutation detection. The gene is composed of 8 exons and spans only 5 kb. Eight (7 novel) different mutations were found in seven patients with a confirmed phosphomannose isomerase deficiency, analyzed in the context of this study: six missense mutations, a splice mutation and one insertion. In the last, the mutation resulted in an unstable transcript, and was hardly detectable at the mRNA level. This emphasizes the importance of mutation analysis at the genomic DNA level. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)247-252
Number of pages6
JournalHuman Mutation
Volume16
Issue number3
DOIs
StatePublished - 2000

Fingerprint

Mannose-6-Phosphate Isomerase
Congenital Disorders of Glycosylation
Mutation
Genes
Protein-Losing Enteropathies
Gene Order
Insertional Mutagenesis
Missense Mutation
Exons
Glycoproteins
Messenger RNA
DNA
Serum

Keywords

  • Carbohydrate deficient glycoprotein syndrome
  • CDG
  • Mannose therapy
  • Mannosephosphate isomerase
  • Metabolic disorders
  • MPI
  • Mutation database
  • Phosphomannose isomerase

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib). / Schollen, E.; Dorland, L.; De Koning, T. J.; Van Diggelen, O. P.; Huijmans, J. G M; Marquardt, T.; Babovic-Vuksanovic, Dusica; Patterson, M.; Imtiaz, F.; Winchester, B.; Adamowicz, M.; Pronicka, E.; Freeze, H.; Matthijs, G.

In: Human Mutation, Vol. 16, No. 3, 2000, p. 247-252.

Research output: Contribution to journalArticle

Schollen, E, Dorland, L, De Koning, TJ, Van Diggelen, OP, Huijmans, JGM, Marquardt, T, Babovic-Vuksanovic, D, Patterson, M, Imtiaz, F, Winchester, B, Adamowicz, M, Pronicka, E, Freeze, H & Matthijs, G 2000, 'Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib)', Human Mutation, vol. 16, no. 3, pp. 247-252. https://doi.org/10.1002/1098-1004(200009)16:3<247::AID-HUMU7>3.0.CO;2-A
Schollen, E. ; Dorland, L. ; De Koning, T. J. ; Van Diggelen, O. P. ; Huijmans, J. G M ; Marquardt, T. ; Babovic-Vuksanovic, Dusica ; Patterson, M. ; Imtiaz, F. ; Winchester, B. ; Adamowicz, M. ; Pronicka, E. ; Freeze, H. ; Matthijs, G. / Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib). In: Human Mutation. 2000 ; Vol. 16, No. 3. pp. 247-252.
@article{d29075e617994e6abbb7787729012c6a,
title = "Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib)",
abstract = "CDG-Ib is the 'gastro-intestinal' type of the congenital disorders of glycosylation (CDG) and a potentially treatable disorder. It has been described in patients presenting with congenital hepatic fibrosis and protein losing enteropathy. The symptoms result from hypoglycosylation of serum and other glycoproteins. CDG-Ib is caused by a deficiency of mannose-6-phosphate isomerase (synonym: phosphomannose isomerase, EC 5.3.1.8), due to mutations in the MPI gene. We determined the genomic structure of the MPI gene in order to simplify mutation detection. The gene is composed of 8 exons and spans only 5 kb. Eight (7 novel) different mutations were found in seven patients with a confirmed phosphomannose isomerase deficiency, analyzed in the context of this study: six missense mutations, a splice mutation and one insertion. In the last, the mutation resulted in an unstable transcript, and was hardly detectable at the mRNA level. This emphasizes the importance of mutation analysis at the genomic DNA level. (C) 2000 Wiley-Liss, Inc.",
keywords = "Carbohydrate deficient glycoprotein syndrome, CDG, Mannose therapy, Mannosephosphate isomerase, Metabolic disorders, MPI, Mutation database, Phosphomannose isomerase",
author = "E. Schollen and L. Dorland and {De Koning}, {T. J.} and {Van Diggelen}, {O. P.} and Huijmans, {J. G M} and T. Marquardt and Dusica Babovic-Vuksanovic and M. Patterson and F. Imtiaz and B. Winchester and M. Adamowicz and E. Pronicka and H. Freeze and G. Matthijs",
year = "2000",
doi = "10.1002/1098-1004(200009)16:3<247::AID-HUMU7>3.0.CO;2-A",
language = "English (US)",
volume = "16",
pages = "247--252",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorders of glycosylation type Ib (CDG-Ib)

AU - Schollen, E.

AU - Dorland, L.

AU - De Koning, T. J.

AU - Van Diggelen, O. P.

AU - Huijmans, J. G M

AU - Marquardt, T.

AU - Babovic-Vuksanovic, Dusica

AU - Patterson, M.

AU - Imtiaz, F.

AU - Winchester, B.

AU - Adamowicz, M.

AU - Pronicka, E.

AU - Freeze, H.

AU - Matthijs, G.

PY - 2000

Y1 - 2000

N2 - CDG-Ib is the 'gastro-intestinal' type of the congenital disorders of glycosylation (CDG) and a potentially treatable disorder. It has been described in patients presenting with congenital hepatic fibrosis and protein losing enteropathy. The symptoms result from hypoglycosylation of serum and other glycoproteins. CDG-Ib is caused by a deficiency of mannose-6-phosphate isomerase (synonym: phosphomannose isomerase, EC 5.3.1.8), due to mutations in the MPI gene. We determined the genomic structure of the MPI gene in order to simplify mutation detection. The gene is composed of 8 exons and spans only 5 kb. Eight (7 novel) different mutations were found in seven patients with a confirmed phosphomannose isomerase deficiency, analyzed in the context of this study: six missense mutations, a splice mutation and one insertion. In the last, the mutation resulted in an unstable transcript, and was hardly detectable at the mRNA level. This emphasizes the importance of mutation analysis at the genomic DNA level. (C) 2000 Wiley-Liss, Inc.

AB - CDG-Ib is the 'gastro-intestinal' type of the congenital disorders of glycosylation (CDG) and a potentially treatable disorder. It has been described in patients presenting with congenital hepatic fibrosis and protein losing enteropathy. The symptoms result from hypoglycosylation of serum and other glycoproteins. CDG-Ib is caused by a deficiency of mannose-6-phosphate isomerase (synonym: phosphomannose isomerase, EC 5.3.1.8), due to mutations in the MPI gene. We determined the genomic structure of the MPI gene in order to simplify mutation detection. The gene is composed of 8 exons and spans only 5 kb. Eight (7 novel) different mutations were found in seven patients with a confirmed phosphomannose isomerase deficiency, analyzed in the context of this study: six missense mutations, a splice mutation and one insertion. In the last, the mutation resulted in an unstable transcript, and was hardly detectable at the mRNA level. This emphasizes the importance of mutation analysis at the genomic DNA level. (C) 2000 Wiley-Liss, Inc.

KW - Carbohydrate deficient glycoprotein syndrome

KW - CDG

KW - Mannose therapy

KW - Mannosephosphate isomerase

KW - Metabolic disorders

KW - MPI

KW - Mutation database

KW - Phosphomannose isomerase

UR - http://www.scopus.com/inward/record.url?scp=0033856148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033856148&partnerID=8YFLogxK

U2 - 10.1002/1098-1004(200009)16:3<247::AID-HUMU7>3.0.CO;2-A

DO - 10.1002/1098-1004(200009)16:3<247::AID-HUMU7>3.0.CO;2-A

M3 - Article

VL - 16

SP - 247

EP - 252

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 3

ER -